Lung cancer: CT guided BX-EBUS: How and when?

IF 0.9 4区 医学 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Hellenic journal of nuclear medicine Pub Date : 2023-05-01
Miltiadis Krokidis
{"title":"Lung cancer: CT guided BX-EBUS: How and when?","authors":"Miltiadis Krokidis","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Histological diagnosis is mandatory for the majority of solid lesions in the lungs in order to characterize the lesions but also to assess the response to treatment. Flexible bronchoscopy has a variable and often poor success rate in sampling pulmonary lesions which are not visible endoscopically. Such focal radiological opacities without endobronchial extension are referred to as peripheral pulmonary lesions and sampling is usually performed under guidance with computed tomography that is a safe and effective technique and became a common procedure representing an essential step for diagnosis and treatment planning. It is usually performed with an 18G or 20G coaxial needle system and several novel guidance and navigation tools may be integrated to clinical practice to offer more accurate lesion targeting. There is however still a percentage of negative sampling a recent study revealed that small lesion size, lower <sup>18</sup>F-FDG uptake or location at the lung bases may lead to inconclusive histology. The diagnostic yield may be increased if PET/CT fusion imaging is used intraprocedurally. CT guided biopsies may also be applied in the same setup with interventions such as ablation of lung lesions offering a \"one-stop\" approach for such patients.</p>","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":"26 Suppl ","pages":"21"},"PeriodicalIF":0.9000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hellenic journal of nuclear medicine","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Histological diagnosis is mandatory for the majority of solid lesions in the lungs in order to characterize the lesions but also to assess the response to treatment. Flexible bronchoscopy has a variable and often poor success rate in sampling pulmonary lesions which are not visible endoscopically. Such focal radiological opacities without endobronchial extension are referred to as peripheral pulmonary lesions and sampling is usually performed under guidance with computed tomography that is a safe and effective technique and became a common procedure representing an essential step for diagnosis and treatment planning. It is usually performed with an 18G or 20G coaxial needle system and several novel guidance and navigation tools may be integrated to clinical practice to offer more accurate lesion targeting. There is however still a percentage of negative sampling a recent study revealed that small lesion size, lower 18F-FDG uptake or location at the lung bases may lead to inconclusive histology. The diagnostic yield may be increased if PET/CT fusion imaging is used intraprocedurally. CT guided biopsies may also be applied in the same setup with interventions such as ablation of lung lesions offering a "one-stop" approach for such patients.

癌症:CT引导的BX-EBUS:如何以及何时?
组织学诊断对于肺部的大多数实体性病变是强制性的,以表征病变,同时评估对治疗的反应。柔性支气管镜在对内镜下看不到的肺部病变进行采样时,成功率可变,而且往往很低。这种没有支气管内膜扩张的局灶性放射学混浊被称为周围性肺部病变,通常在计算机断层扫描的指导下进行采样,这是一种安全有效的技术,已成为一种常见的程序,代表着诊断和治疗计划的重要步骤。它通常使用18G或20G同轴针系统进行,并且可以将几种新型的引导和导航工具集成到临床实践中,以提供更准确的病变靶向。然而,仍有一定比例的阴性采样——最近的一项研究表明,小的病变大小、较低的18F-FDG摄取或位于肺基部可能导致不确定的组织学。如果在手术过程中使用PET/CT融合成像,可以提高诊断率。CT引导的活检也可以应用于相同的设置中,并进行干预,如肺损伤消融,为此类患者提供“一站式”方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.40
自引率
6.70%
发文量
34
审稿时长
>12 weeks
期刊介绍: The Hellenic Journal of Nuclear Medicine published by the Hellenic Society of Nuclear Medicine in Thessaloniki, aims to contribute to research, to education and cover the scientific and professional interests of physicians, in the field of nuclear medicine and in medicine in general. The journal may publish papers of nuclear medicine and also papers that refer to related subjects as dosimetry, computer science, targeting of gene expression, radioimmunoassay, radiation protection, biology, cell trafficking, related historical brief reviews and other related subjects. Original papers are preferred. The journal may after special agreement publish supplements covering important subjects, dully reviewed and subscripted separately.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信